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Original Article
Purpose: The purpose of this prospective multi-institutional study was to evaluate the nutritional status of patients undergoing 
radiotherapy (RT) for treatment of head and neck, lung, or gastrointestinal cancer. 
Materials and Methods: A total of 1,000 patients were enrolled in this study at seven different hospitals in Seoul, Korea 
between October 2009 and May 2010. The nutritional status of patients after receiving 3 weeks of RT was evaluated using 
subjective global assessment (SGA). The nutritional status of each patient was rated as well nourished (A), moderately malnourished 
(B), or severely malnourished (C). 
Results: The mean age of patients in this study was 59.4 ± 11.9 years, and the male to female ratio was 7:3. According to the 
SGA results, 60.8%, 34.5%, and 4.7% of patients were classified as A, B, or C, respectively. The following criteria were significantly 
associated with malnutrition (SGA B or C; p < 0.001): loss of subcutaneous fat or muscle wasting (odds ratio [OR], 11.473); 
increased metabolic demand/stress (OR, 8.688); ankle, sacral edema, or ascites (OR, 3.234); and weight loss ≥5% (OR, 2.299). 
Conclusion: SGA was applied successfully to assess the nutritional status of most patients. The prevalence of malnutrition in a 
radiation oncology department was 39.2%. The results of this study serve as a basis for implementation of nutrition intervention to 
patients being treated at radiation oncology departments.
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Introduction
Malnutrition is a potentially serious condition often comorbid 
with cancer and its treatment. The incidence of malnutrition in 
cancer patients has been reported to range from about 10% to 
80% and malnutrition itself was one of the reasons for death 
in up to 20% of cancer patients [1-3]. Malnutrition contributes 
to an increased risk of toxicity, infection, and healthcare costs, 
as well as decreased treatment response, compliance, quality of 
life, and ultimately patient survival [4-6]. Given the importance 
of nutritional status, screening patients at risk for malnutrition 
and providing a nutrition support program is of great concern 
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for patients with cancer [7]. Subjective global assessment 
(SGA) is a validated clinical tool for assessing nutritional status 
and is based on the features of a medical history and physical 
examination [8]. First described more than two decades ago, 
SGA is still being successfully used as a standardized method 
of assessing nutritional status in various patient populations, 
including those with cancer [7-12]. Furthermore, nutritional 
status using SGA was associated with prognosis and quality of 
life in cancer patients [13-15].
  The acute reaction of the aerodigestive tract as a result 
of undergoing radiotherapy (RT) is associated with diverse 
gastrointestinal symptoms and decreased food intake, resulting 
in deterioration of the patient’s nutritional status [16]. Several 
prospective, randomized trials have reported the effectiveness 
of early nutritional intervention on the quality of life in 
cancer patients undergoing RT [17-20]. Despite the frequent 
occurrence of nutritionally related side effects, a nutritional 
assessment of patients with cancer receiving RT is not routine 
practice in the clinical setting. There has been no study as 
of yet investigating the prevalence of malnutrition during 
Fig. 1. Feature of subjective global 
assessment by Detsky et al. [8].
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radiotherapy in Korea. This prospective multi-institutional 
study was performed to evaluate the nutritional status using 
SGA in ambulatory patients undergoing RT to the head, neck, 
thorax, abdomen, and pelvic area. 
Materials and Methods
1. Participants
This prospective study was designed to investigate the 
nutritional status of patients with cancer receiving RT. 
Between October 2009 and May 2010, consecutive 1,000 
patients were enrolled in seven different hospitals in Seoul, 
Korea. Eligibility criteria included: 1) having primary cancer 
of the head and neck, lung, or gastrointestinal tract; 2) 
receiving RT over a period of 3 weeks to the primary tumor 
site, regardless of RT intent (primary, adjuvant to surgery, 
combined with chemotherapy, or palliation); and 3) willing 
and able to give written informed consent. We concerned the 
acute radiation response of the aerodigestive tract. So, the 
patients treated with RT over 3 weeks to the head and neck, 
lung, or gastrointestinal tract were enrolled. Patients who were 
Table 1. Patients and nutritional characteristics of all subjects
Characteristic Value
Age (yr)
Sex
Tumor site
Chemotherapy
Weight loss in past 6 mo (kg)
Percent weight loss in past 6 mo (%)
Weight change in previous 2 wk
Dietary intake change
Duration of diet change (wk)
Type of diet change
Nausea
Vomiting
Diarrhea
Anorexia
Functional capacity
Duration of dysfunction (wk)
Type of dysfunction
Metabolic demand/stress
Loss of subcutaneous fat
Male
Female
Head and neck
Gastrointesti-
nal tract
Lung
No
Yes
Increase
No change
Decrease
Unknown
No
Yes
Suboptimal 
solid diet
Liquid diet
Starvation
Unknown
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
Suboptimal 
Ambulatory
Bedridden
Unknown
No
Low
Moderate
High
Unknown
Normal
Mild
Moderate
Severe
59.4 ± 11.9
703 (70.3)
297 (29.7)
286 (28.6)
444 (44.4)
270 (27.0)
528 (52.8)
472 (47.2)
2.1 ± 3.9
3.9 ± 4.8
110 (11.0)
590 (59.0)
275 (27.5)
25 (2.5)
667 (66.7)
331 (33.1)
3.8 ± 7.3
174 (17.4)
66 (6.6)
  6 (0.6)
85 (8.5)
701 (70.1)
299 (29.9)
909 (90.9)
91 (9.1)
912 (91.2)
88 (8.8)
494 (49.4)
506 (50.6)
619 (61.9)
380 (38.0)
9.2 ± 26.3
222 (22.2)
134 (13.4)
14 (1.4)
10 (1.0)
123 (12.3)
661 (66.1)
174 (17.4)
32 (3.2)
10 (1.0)
631 (63.1)
254 (25.4)
104 (10.4)
11 (1.1)
Table 1. Continued
Characteristic Value
Muscle wasting
Ankle edema
Sacral edema
Ascites
Subjective global assessment
Normal
Mild
Moderate
Severe
Unknown
Normal
Mild
Moderate
Severe
Normal
Mild
Moderate
Severe
Normal
Mild
Moderate
Severe
Unknown
Well nourished
Moderately  
malnourished
Severely  
malnourished
675 (67.5)
221 (22.1)
91 (9.1)
12 (1.2)
  1 (0.1)
901 (90.1)
62 (6.2)
33 (3.3)
  4 (0.4)
915 (91.5)
48 (4.8)
33 (3.3)
  4 (0.4)
902 (90.2)
44 (4.4)
34 (3.4)
  4 (0.4)
16 (1.6)
608 (60.8)
345 (34.5)
47 (4.7)
Values are presented as mean ± standard deviation or number (%).
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Table 2. Patient and nutritional characteristics of subjects according to subjective global assessment category
Characteristic Status Well nourished (A) Malnourished (B and C) p-value
Age (yr)
Sex
Tumor site
Chemotherapy
Percent weight loss in past 6 mo (%)
Weight change in previous 2 wk
Dietary intake change
Nausea
Vomiting
Diarrhea
Anorexia
Functional capacity
Metabolic demand/stress
Loss of subcutaneous fat
Muscle wasting
Ankle edema
<60
≥60
Male
Female
Head and neck
Gastrointestinal tract
Lung
No
Yes
<5
≥5
Increase or no change
Decrease
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No or low
Moderate or high
No
Yes
No
Yes
No
Yes
293
315
419
189
172
275
161
342
266
496
108
496
100
478
130
464
144
588
20
565
43
373
235
423
185
570
36
528
80
525
83
576
32
(48.2)
(51.8)
(68.9)
(31.1)
(28.3)
(45.2)
(26.5)
(56.3)
(43.8)
(81.6)
(17.8)
(81.6)
(16.4)
(78.6)
(21.4)
(76.3)
(23.7)
(96.7)
(3.3)
(92.9)
(7.1)
(61.3)
(38.7)
(69.6)
(30.4)
(93.8)
(5.9)
(86.8)
(13.2)
(86.3)
(13.7)
(94.7)
(5.3)
169
223
284
108
114
169
109
186
206
167
223
204
175
189
201
237
155
321
71
347
45
121
271
196
195
214
170
103
289
150
241
325
67
(43.1)
(56.9)
(72.4)
(27.6)
(29.1)
(43.1)
(27.8)
(47.4)
(52.6)
(42.6)
(56.9)
(52.0)
(44.6)
(48.2)
(51.3)
(60.5)
(39.5)
(81.9)
(18.1)
(88.5)
(11.5)
(30.9)
(69.1)
(50.0)
(49.7)
(54.6)
(43.4)
(26.3)
(73.7)
(38.3)
(61.5)
(82.9)
(17.1)
0.116
0.232
0.799
0.006
<0.001
<0.001
<0.001
<0.001
<0.001
0.016
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
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obviously moribund, not willing to participate, or not able to 
respond during interview were excluded. The ethics committee 
of each study hospital approved the study protocol.
2. Nutritional assessment and data collection
The nutritional status of each patient was assessed 3 weeks 
after the initiation of RT, and was determined using SGA 
tool [8]. The 3-week period between RT commencement and 
nutritional assessment was chosen because RT-induced acute 
toxicity, such as mucositis, develops during this period. The 
SGA tool is based on a medical history (weight loss; dietary 
intake change; gastrointestinal symptoms including nausea, 
vomiting, diarrhea and anorexia; and changes in functional 
capacity) and physical examination (loss of subcutaneous 
fat; muscle wasting; ankle edema, sacral edema, and ascites). 
Each patient was classified as either well nourished (SGA A), 
moderately or suspected of being malnourished (SGA B), or 
severely malnourished (SGA C). This classification was assigned 
on the basis of subjective weighting. The details of SGA 
assessment was described by Detsky et al. [8] (Fig. 1). For the 
purpose of this analysis, malnutrition was defined as either 
SGA B or SGA C. A single trained rater (physician or dietitian) 
in each hospital assessed nutritional status. In order to 
minimize inter-rater variation, all raters were educated by the 
principle dietician of the coordinating study center. In addition 
to recording nutritional information, the following information 
was collected from the medical record within 4 weeks before 
or during RT: age, sex, diagnosis, and chemotherapy.
3. Statistical analysis
All continuous variables and categorical variables were 
transformed into two categorical variables. Univariate analysis 
was conducted by performing chi-square tests to compare the 
association between SGA criteria and malnutrition. To identify 
independent risk factors for malnutrition, binary logistic 
regression analysis was performed. Significance was defined as 
p < 0.05. Data were analyzed using SPSS ver. 18.0 (SPSS Inc., 
Chicago, IL, USA). 
Results
1. Characteristics and nutritional status of participants
Baseline characteristics of the participants are shown in Table 
1. The mean age of enrolled subjects was 59.4 ± 11.9 years. Of 
the total 1,000 patients, 703 (70.3%) were men and 293 (29.3%) 
were women. Gastrointestinal cancer, including esophageal 
cancer, was the most the common parameter and was present 
in 444 of the patients. Head and neck cancer and lung 
cancer affected 286 patients and 270 patients, respectively. 
Chemotherapy was performed either during RT or within the 4 
weeks before RT in 472 patients. According to SGA, 608 (60.8%), 
345 (34.5%), and 47 (4.7%) patients were SGA A, SGA B, and 
SGA C, respectively. 
2. Impact of SGA parameters and clinical factors on 
malnutrition
Table 2 shows the results of univariate analysis of clinical 
factors and SGA parameters for each SGA classification. For 
this analysis, SGA B and C were grouped together in the 
malnourished category. Additionally, all continuous variables 
were transformed into categorical variables. Except for tumor 
site, all categorical variables were re-coded into two groups. 
There was no significant association between malnutrition (SGA 
B and C) and age (p = 0.116), sex (p = 0.232), or tumor site 
(p = 0.799). Chemotherapy in addition to all SGA parameters 
were significantly associated with malnutrition (SGA B and C). 
In a multivariate analysis, similar SGA parameters were coded 
as one (Table 3). Loss of subcutaneous fat or muscle wasting 
strongly was associated with the development of malnutrition 
(odds ratio [OR], 11.473; p < 0.001). Metabolic demand/stress 
was the next most strongly contributing factor (OR, 8.688; p 
< 0.001). Patients with ankle, sacral edema, or ascites upon 
Table 2. Continued
Characteristic Status Well nourished (A) Malnourished (B and C) p-value
Sacral edema
Ascites
No
Yes
No
Yes
578
30
563
30
(95.1)
(4.9)
(92.6)
(4.9)
337
55
339
52
(86.0)
(14.0)
(86.5)
(13.3)
<0.001
<0.001
Values are presented as number (%).
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physical examination were also at a higher risk of being 
malnourished (OR, 3.234; p < 0.001). Additionally, patients 
with ≥5% weight loss in the previous 6 months were also 
more likely than other patients to be malnourished (OR, 2.299; 
p < 0.001).
Discussion and Conclusion
Three weeks after initiation of RT, we used SGA to evaluate the 
nutritional status of ambulatory patients with cancer whose 
site of treatment varied. SGA was applied successfully to 
assess the nutritional status of most patients. The prevalence 
of patients who were malnourished or at risk of becoming 
malnourished while being treated at one of the seven hospitals 
in the study population was high at 39.2%.
  Malnutrition is common in cancer patients, and has been 
reported to occur in up to 80% of patients treated with 
RT. Furthermore, malnutrition is associated with increased 
morbidity and mortality [2,6]. It has been suggested that 
malnutrition increases the risk of infections caused by immune 
dysfunction, as well as decreasing quality of life and survival 
[4]. Moreover, malnutrition adversely affects patients’ response 
to cancer treatment and increases the incidence of treatment-
related toxicities. Oncologic treatment exacerbates acute and 
chronic symptoms due to issues with poor food intake and 
poor nutritional status [21]. Most of the RT-related toxicities 
are closely associated with nutritional problems [16]. Given the 
deteriorating side effect of RT, several prospective, randomized 
trials have been conducted to evaluate the effectiveness 
of nutritional intervention on the quality of life as well as 
nutritional status in patients with cancer undergoing RT 
[17-20,22,23]. Consistently, the nutritional intervention 
positively influenced weight, nutritional status, and quality 
of life compared to usual care in patients receiving RT to the 
gastrointestinal or head and neck area [17,19,20,22]. Therefore, 
early identification of malnutrition in cancer patients and 
nutritional intervention may increase tolerance to cancer 
treatment and improve quality of life and prognosis [3,4,24,25]. 
  Many nutrition screening tools have been proposed that 
combine multiple components, including dietary and medical 
history, weight loss, biochemical indicators of body protein, 
and anthropometry [26]. SGA for determining nutritional 
status was developed by Detsky et al. [8] in 1987. This 
assessment tool is simple, non-invasive, and inexpensive, 
consisting of a medical history (weight change, dietary intake 
change, gastrointestinal symptoms, and changes in functional 
capacity) and a physical examination (loss of subcutaneous 
fat, muscle wasting, ankle edema, sacral edema, and ascites). 
SGA categorizes patients into three nutritional status groups: 
well nourished (SGA A), moderately malnourished (SGA B), and 
severely malnourished (SGA C). 
  SGA is a reliable tool that that enables correlation of a 
number of objective nutritional assessment indicators, such 
as morbidity, mortality, and quality of life (QoL) measures, and 
has been used universally in diverse clinical settings, various 
regions, and multicenter studies [7,9-12,27,28]. A limitation of 
using SGA is that it only classifies subjects into three general 
groups, and it does not reflect subtle changes in nutritional 
status. Ottery [7] developed a patient-generated SGA tool 
using a scoring system for patients with cancer that allowed 
data to be expressed as a continuous measurement. Using this 
tool, investigators can detect subtle changes of nutritional 
status. For more than two decades, however, the original SGA 
has been used to assess patient malnutrition in several clinical 
settings and is the standard method [27]. In this study, we 
have successfully conducted nutritional surveys using SGA in 
multiple institutions, using rater education to support optimal 
consistency. According to SGA, the prevalence of malnutrition 
in this study population was 39.2%. This finding is similar to 
the 35% of patients who were malnourished in the Australian 
Radiation Oncology Facilities as determined by patient-
generated SGA [28]. We demonstrated the malnutrition in 
large number of ambulatory patients undergoing RT. This 
is first step to raise concern about nutrition assessment at 
Table 3. Independent risk factors for malnourishment (subjective 
global assessment B and C)
OR (95% CI) p-value
Chemotherapy
Percent weight loss in past 
6 mo
Dietary intake change
Nausea/vomiting
Diarrhea
Anorexia
Functional capacity
Metabolic demand/stress
Loss of subcutaneous fat or 
muscle wasting
Ankle, sacral edema or 
ascites
1.180
2.299
1.407
1.080
1.412
2.018
1.105
8.688
11.473
3.234
(0.821-1.697)
(1.567-3.373)
(0.911-2.172)
(0.703-1.661)
(0.723-2.756)
(1.356-3.004)
(0.736-1.658)
(5.319-14.192)
(7.588-17.347)
(1.716-6.094)
0.370
<0.001
0.124
0.724
0.312
0.001
0.632
<0.001
<0.001
<0.001
OR, odds ratio; CI, confidence interval.
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radiation oncology departments.
  The group of patients enrolled this study is very hetero-
geneous and includes various levels of tumor burden and 
RT protocol across multiple institutions. In addition, RT 
parameters such as dose and volume were variable. RT-related 
toxicities associated with nutritional problems were not be 
evaluated. This study did not investigate inter-rater reliability 
or reproducibility. To minimize observer bias, SGA assessment 
was performed after a training period that took place over 
a few days. A well-trained observer can distinguish between 
malnourished (SGA categories B and C) and normal patients, 
although they had more difficulty discriminating between 
moderate and severe malnutrition [29]. This study applied 
the SGA only at one time point and is observational because 
no nutritional intervention was performed. Nevertheless, our 
study analyzed a large population of patients with cancer 
receiving RT and adds the clinically useful information that 
malnutrition is an important problem in cancer patients 
undergoing RT. Further studies are needed to evaluate the 
effectiveness of nutritional intervention at several time 
points in a homogenous group of patients to determine the 
benefit of nutritional support on clinical outcomes in cancer 
patients treated with RT. In conclusion, this study identified 
the prevalence of malnutrition using the SGA tool in patients 
treated with RT to the head and neck, thorax, abdomen and 
pelvic area. Thirty-nine point two percent of patients were 
moderately or suspected of being malnourished or severely 
malnourished. The results of this study serve as a basis for 
implementation of nutrition intervention to patients being 
treated at radiation oncology departments.
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